MEFIDMY Trademark

Trademark Overview


On Thursday, October 13, 2022, a trademark application was filed for MEFIDMY with the United States Patent and Trademark Office. The USPTO has given the MEFIDMY trademark a serial number of 97631025. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, October 16, 2024. This trademark is owned by Pfizer Inc.. The MEFIDMY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; Pharmaceutical preparations for treatment of dermatomyositis
mefidmy

General Information


Serial Number97631025
Word MarkMEFIDMY
Filing DateThursday, October 13, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, October 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 5, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; Pharmaceutical preparations for treatment of dermatomyositis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 27, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Trademark Events


Event DateEvent Description
Monday, October 17, 2022NEW APPLICATION ENTERED
Thursday, October 27, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 26, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 27, 2023ASSIGNED TO EXAMINER
Wednesday, August 2, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, August 2, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, August 2, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 2, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, August 2, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 16, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 5, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 31, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, March 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 15, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, March 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 25, 2024SOU EXTENSION 1 FILED
Wednesday, October 16, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, October 16, 2024SOU EXTENSION 2 FILED
Wednesday, October 16, 2024SOU EXTENSION 2 GRANTED
Wednesday, October 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 25, 2024SOU TEAS EXTENSION RECEIVED
Monday, March 25, 2024SOU EXTENSION 1 GRANTED